[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355538-105":59,"doc-detail-355538-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","design-of-synthetic-selenopeptides-with-antioxidant-activity-for-the-treatment-of-xp-and-non-melanoma-skin-cancer","Design of synthetic selenopeptides with antioxidant activity for the treatment of XP and non-melanoma skin cancer","","Design of synthetic selenopeptides is investigated as a potential treatment strategy for Xeroderma Pigmentosum (XP) and non-melanoma skin cancer. XP is driven by defective nucleotide excision repair, leading to persistent UV-induced DNA lesions and heightened cancer susceptibility. The work leverages antioxidant and photoprotective properties attributed to selenocysteine-containing selenopeptides. In silico optimization produced five novel sequences, with Selera-2 selected for physicochemical and structural suitability and assessed by docking against therapeutic targets.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/design-of-synthetic-selenopeptides-with-antioxidant-activity-for-the-treatment-of-xp-and-non-melanoma-skin-cancer/355538/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/design-of-synthetic-selenopeptides-with-antioxidant-activity-for-the-treatment-of-xp-and-non-melanoma-skin-cancer/355538.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",17,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is Xeroderma Pigmentosum (XP) and why is it clinically significant?","Question",{"text":113,"@type":114},"XP is a rare autosomal recessive disorder marked by extreme sensitivity to ultraviolet light. Defective nucleotide excision repair leads to accumulated DNA lesions and increased susceptibility to skin malignancies.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What approach does the study use to develop synthetic selenopeptides?",{"text":118,"@type":114},"The study designs five novel selenopeptide sequences using bioinformatic tools. Selera-2 is selected based on physicochemical and structural properties and is then evaluated through docking analysis with therapeutic targets.",{"name":120,"@type":111,"acceptedAnswer":121},"Which therapeutic targets and outcomes are highlighted in the docking and validation results?",{"text":122,"@type":114},"Docking models indicate stable binding for B-RAF and TrxR1, supported by low binding energy levels and molecular dynamics profiles. The work also proposes a recombinant expression plasmid vector for future experimental trials.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355538,1790177131,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","TYPE Original Research PUBLISHED 09 April 2026  \nDOI 10.3389/fsysb.2026.1686085  \nOPEN ACCESS  \nEDITED BY  \nYoram Vodovotz,  \nUniversity of Pittsburgh, United States  \nREVIEWED BY  \nProsper Obed Chukwuemeka, University of Pittsburgh, United States Geovan Figueirêdo De Sá-Filho, Federal University Rural Semi-Arid, Brazil  \n*CORRESPONDENCE  \nAndré Kipnis,  [akipnis@ufg.br](akipnis@ufg.br)  \nRECEIVED 14 August 2025  \nREVISED 24 October 2025  \nACCEPTED 05 March 2026  \nPUBLISHED 09 April 2026  \nCITATION  \nCoelho AA, Dias EPS and Kipnis A (2026) Design of synthetic selenopeptides with antioxidant activity for the treatment of XP and non-melanoma skin cancer.  \nFront. Syst. Biol. 6:1686085 .  \ndoi: 10.3389/fsysb.2026.1686085  \nCOPYRIGHT  \n© 2026 Coelho, Dias and Kipnis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nDesign of synthetic selenopeptides with antioxidant activity for the treatment of XP and non-melanoma skin cancer  \nArthur Alves Coelho 1,2, Eduarda Pereira Soares Dias 3,4 and André Kipnis 3*  \n1Laboratory of Immunology of Infectious Diseases, Institute of Tropical Pathology and Public Health, Universidade Federal de Goiás, Goiânia, Brazil, 2Laboratory of Genetic and Genomic, School of Agronomy, Universidade Federal de Goiás, Goiânia, Brazil, 3Laboratory of Molecular Bacteriology, Institute of Tropical Pathology and Public Health, Universidade Federal de Goiás, Goiânia, Brazil, 4Laboratory of Vaccinology, Technological Development Center, Universidade Federal de Pelotas, Pelotas, Brazil  \nIntroduction: Xeroderma Pigmentosum (XP) is a rare, autosomal recessive disorder characterized by extreme sensitivity to ultraviolet (UV) light. Current treatments primarily focus on symptom management and surgical tumor excisions. Selenopeptides, which possess a modified residue of Cysteine (Selenocysteine), are distinguished for their antioxidant and photoprotective properties. These properties could be beneficial in counteracting the oxidative DNA damage observed in XP lesions.  \nObjective: Building upon the work initiated by the Brazilian SynBio UFG iGEM Design League team, this study aimed to develop a new approach for designing and expressing synthetic selenopeptides through in silico optimization, to target both XP and non-melanoma skin cancers.  \nMethods: Five novel sequences of selenopeptides, named Selera, were designed and evaluated through bioinformatic tools. Selera-2 was chosen as the best model designed for its physico-chemical and structural properties and was submitted to docking analysis with therapeutic targets.  \nResults and Discussion: Docking models of B-RAF and TrxR1 demonstrated to bethe most stable binding sites, considering low-binding energy levels and molecular dynamics profile, suggesting possible targets for anti tumor effect. Anew recombinant expression plasmid vector was proposed, p-Sec Reg 1, in order to ensure optimal expression for future trials and production. The in silico validation of this innovative approach allows the creation of novelselenopeptides and their prospective applications in the treatment of XP and other skin cancer conditions.  \nKEYWORDS  \nxeroderma pigmentosum, synthetic biology, peptide design, bioengineering, skin cancer  \n1 Introduction  \nXeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by an extreme sensitivity to ultraviolet light (UV) (Lucero and Horowitz, 2023) . This disease results from a failure in nucleotide excision repair (NER), which is responsible for correcting damaged DNA induced by UV radiation, chemical agents, and other environmental f","cbCaiqwcU6aGrMOx","https://ap.wps.com/l/cbCaiqwcU6aGrMOx","pdf",4057741,14,"English","# Introduction\n## Objective\n## Methods\n## Results and Discussion\n# Keywords\n## Background on XP","[{\"question\":\"What is Xeroderma Pigmentosum (XP) and why is it clinically significant?\",\"answer\":\"XP is a rare autosomal recessive disorder marked by extreme sensitivity to ultraviolet light. Defective nucleotide excision repair leads to accumulated DNA lesions and increased susceptibility to skin malignancies.\"},{\"question\":\"What approach does the study use to develop synthetic selenopeptides?\",\"answer\":\"The study designs five novel selenopeptide sequences using bioinformatic tools. Selera-2 is selected based on physicochemical and structural properties and is then evaluated through docking analysis with therapeutic targets.\"},{\"question\":\"Which therapeutic targets and outcomes are highlighted in the docking and validation results?\",\"answer\":\"Docking models indicate stable binding for B-RAF and TrxR1, supported by low binding energy levels and molecular dynamics profiles. The work also proposes a recombinant expression plasmid vector for future experimental trials.\"}]","Design of synthetic selenopeptides with antioxidant activity for the treatment of XP and non-melanoma skin cancer | PDF",1790119696,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5fe68ea9dc01ce3d569153768681bcb.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f0380a283ffc2f38bfd537bb85a94c8.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d289e12b75192fc096179f7b4cad8483.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6dd29326543c684c60194e7e2921c9d3.webp",980,1385]